EXICURE, INC. Financing Cash Flow
EXICURE, INC. (XCUR) reported Financing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- EXICURE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- EXICURE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- EXICURE, INC. net cash provided by (used in) financing activities for fiscal 2025 was $1.60M, a 88.06% decline from fiscal 2024.
- EXICURE, INC. net cash provided by (used in) financing activities for fiscal 2024 was $13.40M, a 264.78% increase from fiscal 2023.
- EXICURE, INC. net cash provided by (used in) financing activities for fiscal 2023 was $3.67M.
- EXICURE, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$3.10M, a 378.23% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-29 | $0.00 derived: sum of 2 quarters · filed 2026-05-29 | $0.00 derived: sum of 3 quarters · filed 2026-05-29 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $1.60M 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $1.60M 10-Q · filed 2025-11-07 | $14.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.60M 10-Q · filed 2026-08-14 | $14.00M derived: sum of 3 quarters · filed 2026-08-14 | $14.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-29 | $14.00M derived: sum of 2 quarters · filed 2026-05-29 | $14.00M derived: sum of 3 quarters · filed 2026-05-29 | $15.00M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $12.40M derived: sum of 2 quarters · filed 2026-03-25 | $13.40M derived: sum of 3 quarters · filed 2026-03-25 | $13.40M 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.00M derived: sum of 2 quarters · filed 2025-11-07 | $1.00M 10-Q · filed 2025-11-07 | $999.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.00M 10-Q · filed 2025-08-08 | $999.00K derived: sum of 3 quarters · filed 2025-08-08 | $998.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-06-27 | -$1.00K derived: sum of 2 quarters · filed 2025-06-27 | -$2.00K derived: sum of 3 quarters · filed 2025-06-27 | -$921.00K derived: sum of 4 quarters · filed 2025-06-27 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.00K derived: sum of 2 quarters · filed 2025-03-18 | -$921.00K derived: sum of 3 quarters · filed 2025-03-18 | $3.67M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$920.00K derived: sum of 2 quarters · filed 2024-11-14 | $3.67M 10-Q · filed 2024-11-14 | $3.67M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $3.68M 10-Q · filed 2024-08-13 | $3.68M derived: sum of 3 quarters · filed 2024-08-13 | $3.67M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.59M 10-Q · filed 2024-06-17 | $4.59M derived: sum of 2 quarters · filed 2024-06-17 | $4.59M derived: sum of 3 quarters · filed 2024-06-17 | $9.48M derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | -$2.00K derived: sum of 2 quarters · filed 2024-06-06 | $4.89M derived: sum of 3 quarters · filed 2024-06-06 | -$3.10M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $4.89M derived: sum of 2 quarters · filed 2024-06-06 | -$3.10M 10-Q · filed 2024-05-16 | -$2.66M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $4.89M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | -$3.10M 10-Q/A · filed 2024-06-06 | -$2.65M derived: sum of 3 quarters · filed 2024-06-06 | -$2.66M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | -$7.99M 10-Q/A · filed 2024-06-06 | -$7.54M derived: sum of 2 quarters · filed 2024-06-06 | -$7.55M derived: sum of 3 quarters · filed 2024-06-06 | -$7.42M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $439.00K derived: sum of 2 quarters · filed 2023-03-27 | $570.00K derived: sum of 3 quarters · filed 2023-03-27 | $1.12M 10-K · filed 2023-03-27 |
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $122.00K derived: sum of 2 quarters · filed 2022-11-14 | $668.00K 10-Q · filed 2022-11-14 | $806.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $677.00K 10-Q · filed 2022-08-15 | $815.00K derived: sum of 3 quarters · filed 2022-08-15 | $18.09M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $546.00K 10-Q · filed 2022-05-16 | $684.00K derived: sum of 2 quarters · filed 2022-05-16 | $17.96M derived: sum of 3 quarters · filed 2022-05-16 | $18.01M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $17.41M derived: sum of 2 quarters · filed 2022-03-25 | $17.46M derived: sum of 3 quarters · filed 2022-03-25 | $15.13M 10-K · filed 2022-03-25 |
| 2020-09-30 | $17.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $17.32M derived: sum of 2 quarters · filed 2021-11-19 | $14.99M 10-Q · filed 2021-11-19 | $40.70M derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.28M 10-Q · filed 2021-08-12 | $23.43M derived: sum of 3 quarters · filed 2021-08-12 | $82.06M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$2.33M 10-Q · filed 2021-05-12 | $23.38M derived: sum of 2 quarters · filed 2021-05-12 | $82.01M derived: sum of 3 quarters · filed 2021-05-12 | $82.03M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $25.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $84.34M derived: sum of 2 quarters · filed 2021-03-11 | $84.36M derived: sum of 3 quarters · filed 2021-03-11 | $84.31M 10-K · filed 2021-03-11 |
| 2019-09-30 | $58.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $58.65M derived: sum of 2 quarters · filed 2020-11-12 | $58.60M 10-Q · filed 2020-11-12 | $58.41M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$35.00K 10-Q · filed 2020-08-12 | -$221.00K derived: sum of 3 quarters · filed 2020-08-12 | $20.04M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$52.00K 10-Q · filed 2020-05-14 | -$238.00K derived: sum of 2 quarters · filed 2020-05-14 | $20.03M derived: sum of 3 quarters · filed 2020-05-14 | $20.03M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $20.08M derived: sum of 2 quarters · filed 2020-03-10 | $20.08M derived: sum of 3 quarters · filed 2020-03-10 | $20.09M 10-K · filed 2020-03-10 |
| 2018-09-30 | $20.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $20.26M derived: sum of 2 quarters · filed 2019-11-07 | $20.27M 10-Q · filed 2019-11-07 | $28.64M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $7.00K 10-Q · filed 2019-08-08 | $8.38M derived: sum of 3 quarters · filed 2019-09-23 | $26.82M derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $7.00K 10-Q · filed 2019-05-08 | $8.38M derived: sum of 2 quarters · filed 2019-09-23 | $26.82M derived: sum of 3 quarters · filed 2019-09-23 | |
| 2017-12-31 | $8.37M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $26.81M derived: sum of 2 quarters · filed 2019-09-23 | $26.86M 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | $18.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $18.49M 10-Q · filed 2018-11-06 | ||
| 2017-08-31 | $6.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-09-12 | $18.75K 10-Q · filed 2017-09-12 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $43.00K 10-Q · filed 2018-08-06 | ||
| 2017-05-31 | $12.50K 10-Q · filed 2017-07-11 | |||
| 2017-03-31 | $43.00K 10-Q · filed 2018-05-15 | $50.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.34M 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $6.33M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |